tezacaftor
Generic: tezacaftor·Brand: Alyftrek
tezacaftor: 1 clinical trial tracked.
tezacaftor evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about tezacaftor, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Clinical Trial Registry Records (1)
A Phase 1, Study of VX-828 in Healthy Subjects and in Subjects With Cystic Fibrosis
Primary endpoint: Part A: Safety and Tolerability as Assessed by Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs)
InterventionalRandomizedquadruple165 enrolledStarted 2023-12Completion 2026-0712 sites · United StatesVertex Pharmaceuticals Incorporated